News

2013 WORKING GROUP ON NEW TB DRUGS ANNUAL MEETING IN PARIS, FRANCE ON OCTOBER 29TH


5 Sep 2013
by Working Group

You are invited to join us for the Stop TB Partnership Working Group on New Drugs’ Annual Meeting 2013 at Le Méridien Etoile in Paris, France, on Oct. 29th from 15:00 to 19:00.

This meeting is held before the 44th Union World Conference on Lung Health (The Union). During the meeting we will review and discuss progress of projects in the Global TB Drug Pipeline and Drug Discovery Portfolio, review WGND 2013 activities, and discuss other relevant topics. Representatives from pharmaceutical companies, research consortia and organizations, NGOs and academia will be participating.

The agenda for the meeting is:

WGND Updates

15:00-15:05

Welcome Melvin Spigelman, Co-chair

15:05-15:10

Update from Stop TB Partnership Lucica Ditiu

15:10-15:25

WGND Activities Update Cherise Scott

15:25-15:40

TB Drug Development Year-in-Review Barbara Laughon
Clinical Development of TB Drugs

15:40-15:55

Janssen Pharmaceutical, Inc. Chrispin Kambili

15:55-16:10

Otsuka Pharmaceutical Jeff Hafkin

16:10-16:25

Pan-African Consortium for Evaluation of Anti-TB Antibiotics (PanACEA) Michael Hoelscher

16:25-16:40

Sequella, Inc. Carol Nacy

16:40-16:55

Global Alliance for TB Drug Development (TB Alliance) Christo van Niekerk

16:55-17:10

Coffee Break

17:10-17:25

Tuberculosis Trials Consortium (TBTC) Neil Schluger

17:25-17:40

AIDS Clinical Trials Group (ACTG) Gavin Churchyard

17:40-17:55

INTERTB/St. George’s University of London Amina Jindani
Discovery and Preclinical Development

17:55-18:10

Q203 (Qurient) Kiyean Nam

18:10-18:25

Preclinical Assessment of Novel TB Regimens Dan Everitt

18:25-18:40

Update on Preclinical Research Jacques Grosset

18:40-18:55

GSK Tres Cantos Open Innovation Lab David Barros
Closing

18:55-19:00

Closing and Announcements Barbara Laughon, Co-chair

Please register by sending an e-mail reply to wgnd@newtbdrugs.org.

If you have any questions, please feel free to contact Cherise Scott, WGND Secretariat.

Explore. Learn. Join the Conversation at www.newtbdrugs.org.

More News
23 Aug 2022
Last week, the PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings...
4 May 2022
Earlier this week, the World Health Organization (WHO) released a rapid communication which detailed the upcoming changes to the treatment guidance for drug-resistant tuberculosis (DR-TB). These guidelines are used to inform national TB programmes globally on how to treat patients with these...
5 Apr 2022
On April 01, 2022, the Stop TB Partnership launched the second online consultation for the new Global Plan to End TB 2023-2030. Over the years, the Global Plans have been important tools for advocacy and resource mobilization, and served as a reference document for donors and stakeholders. In May...